AstraZeneca may mount a challenge to GlaxoSmithKline’s three-in-one inhaler for chronic obstructive pulmonary disease (COPD) after a late-stage trial success. AZ’s single inhaler, PT010 ...

Patients with COPD had slightly more major adverse cardiovascular events after initiating single-inhaler triple therapy vs a LABA-ICS inhaler.

[5] Packages containing 6 or 30 capsules with one inhaler device are available ... has not been studied in pediatric patients because COPD does not normally occur in children.

Rate this content's potential impact on patient outcomes Submit Rating Average rating / 5. Vote count: No votes so far! Be ...

Large numbers of hospital admissions, along with poor adherence and the prescribing of inappropriate inhalers ... In COPD, 900,000 people have been diagnosed, while another 2.1 million have ...

The latest road conditions for the state you are calling from can be obtained by calling 5 1 1 ... lines. && COPD Over 30 million Americans have COPD, and most use some form of inhaled medicine ...